Fresenius (company)
Fresenius SE & Co. KGaA is a European multinational health care company based in Bad Homburg vor der Höhe, Germany. It provides products and services for dialysis in hospitals, as well as inpatient and outpatient medical care. The company is involved in hospital management and in engineering and services for medical centers and other health care facilities.
| Company type | Kommanditgesellschaft auf Aktien with Societas Europaea as partner with unlimited liability |
|---|---|
Traded as | FWB: FRE DAX Component |
| ISIN | DE0005785604 |
| Industry | Health care |
| Founded | 1912 |
| Founder | Eduard Fresenius |
| Headquarters | Bad Homburg vor der Höhe, Germany |
Key people | Helen Giza (CEO and chairman of the management board) Wolfgang Kirsch (Chairman of the supervisory board) |
| Products | infusion pumps, medication, hospitals, medical care |
| Services | Dialysis |
| Revenue | €37.250 billion (2021) |
| €4.252 billion (2021) | |
Net income | €1.867 billion (2021) |
| Total assets | €71.962 billion (2021) |
| Total equity | €29.288 billion (2021) |
| Owner | Else Kröner-Fresenius Foundation (26.6%) |
Number of employees | 316,078 (2021) |
| Website | www |
The company is ranked 411th in the Forbes Global 2000 list in 2023.
In March 2022, it announced plans to merge with InterWell Health and Cricket Health to form a new company, which will operate under the InterWell Health brand, focused on services for the earlier stages of kidney disease.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.